Opko Health OPK Pharmaceutical — Goodwill Foreign Currency Translation Gain Loss
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Opko Health in its filing.
Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.
The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opko Health's pharmaceutical — goodwill foreign currency translation gain loss.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opko Health's pharmaceutical — goodwill foreign currency translation gain loss?
- Opko Health (OPK) reported pharmaceutical — goodwill foreign currency translation gain loss of -$1.76M in Q1 2026.
- What does pharmaceutical — goodwill foreign currency translation gain loss mean?
- The impact of fluctuations in foreign exchange rates on the carrying value of goodwill denominated in currencies other than the reporting currency for the pharmaceutical segment. It captures non-cash adjustments resulting from the translation of international pharmaceutical assets.